STOCK TITAN

[Form 4] SCHWAB CHARLES CORP Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Carolyn Schwab-Pomerantz, a director of SCHWAB CHARLES CORP (SCHW), reported sales of company common stock under a Rule 10b5-1 trading plan. On 10/02/2025 she disposed of 14,400 shares at a weighted-average price of $92.5465 and 9,600 shares at a weighted-average price of $92.5545, each sale effected in multiple trades. The filing states the 10b5-1 plan was adopted on August 14, 2024. Following the reported transactions the form lists various beneficial holdings, including 1,434,856.6599 shares indirectly held by a trust and 440,914 shares indirectly held by spouse as trustee; additional holdings of 9,624 and 2,798 shares are also reported with direct or indirect forms. The report is signed by an attorney-in-fact on 10/03/2025.

Carolyn Schwab-Pomerantz, una direttrice della SCHWAB CHARLES CORP (SCHW), ha riportato vendite di azioni comuni della società nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1. Il 02/10/2025 ha svalutato 14.400 azioni a un prezzo medio ponderato di $92,5465 e 9.600 azioni a un prezzo medio ponderato di $92,5545, ogni vendita effettuata in multiple transazioni. Il deposito riporta che il piano 10b5-1 è stato adottato l14 agosto 2024. A seguito delle transazioni riportate, il modulo elenca varie partecipazioni beneficiarie, tra cui 1.434.856,6599 azioni indirettamente detenute da un trust e 440.914 azioni indirettamente detenute dal coniuge in qualità di trustee; ulteriori partecipazioni di 9.624 e 2.798 azioni sono riportate anch'esse con forme dirette o indirette. Il rapporto è firmato da un procuratore-in-facto in data 03/10/2025.

Carolyn Schwab-Pomerantz, una directora de SCHWAB CHARLES CORP (SCHW), reportó ventas de acciones comunes de la empresa bajo un plan de negociación distinto conforme a la Regla 10b5-1. El 02/10/2025 liquidó 14,400 acciones a un precio medio ponderado de $92.5465 y 9,600 acciones a un precio medio ponderado de $92.5545, siendo cada venta realizada en múltiples operaciones. El registro indica que el plan 10b5-1 fue adoptado el 14 de agosto de 2024. Tras las transacciones reportadas, el formulario lista diversas participaciones beneficiosas, incluyendo 1,434,856.6599 acciones indirectamente en poder de un fideicomiso y 440,914 acciones indirectamente en poder del cónyuge como fiduciario; se reportan además participaciones de 9,624 y 2,798 acciones con formas directas o indirectas. El informe está firmado por un apoderado en 03/10/2025.

Carolyn Schwab-Pomerantz는 SCHWAB CHARLES CORP (SCHW)이사로서 회사 보통주를 매매한 것으로 Rule 10b5-1 거래 계획에 따라 매매를 보고했습니다. 2025/10/0214,400주를 가중 평균가 $92.5465로, 9,600주를 가중 평균가 $92.5545로 각 다수의 거래로 매도했습니다. 해당 제출 문서는 10b5-1 계획이 2024년 8월 14일에 채택되었다고 명시합니다. 보고된 거래에 따라 양식은 신탁이 간접적으로 보유한 1,434,856.6599주와 배우자가 신탁 수탁인으로 간접 보유한 440,914주를 포함한 여러 수혜 보유를 나열합니다; 또한 9,624주와 2,798주도 직접 또는 간접 형태로 보고됩니다. 보고서는 2025/10/03에 대리인에 의해 서명되었습니다.

Carolyn Schwab-Pomerantz, directrice de SCHWAB CHARLES CORP (SCHW), a déclaré des ventes d’actions ordinaires de la société dans le cadre d’un plan de négociation conforme à la règle 10b5-1. Le 02/10/2025, elle a cédé 14 400 actions à un prix moyen pondéré de $92,5465 et 9 600 actions à un prix moyen pondéré de $92,5545, chaque vente effectuée en plusieurs transactions. Le dépôt indique que le plan 10b5-1 a été adopté le 14 août 2024. Suite aux transactions signalées, le formulaire répertorie diverses participations bénéficiaires, notamment 1 434 856,6599 actions indirectement détenues par une fiducie et 440 914 actions indirectement détenues par le conjoint en tant que fiduciaire; d’autres participations de 9 624 et 2 798 actions sont également signalées sous des formes directes ou indirectes. Le rapport est signé par un mandataire en 03/10/2025.

Carolyn Schwab-Pomerantz, eine Direktorin der SCHWAB CHARLES CORP (SCHW), meldete Verkäufe von Stammaktien des Unternehmens im Rahmen eines Handelsplans gemäß der Regulierung 10b5-1. Am 02.10.2025 veräußerte sie 14.400 Aktien zu einem gewichteten Durchschnittspreis von $92,5465 und 9.600 Aktien zu einem gewichteten Durchschnittspreis von $92,5545, wobei jeder Verkauf in mehreren Transaktionen erfolgte. Die Einreichung besagt, dass der 10b5-1-Plan am 14. August 2024 angenommen wurde. Nach den gemeldeten Transaktionen listet das Formular verschiedene begünstigte Beteiligungen auf, darunter 1.434.856,6599 Aktien, die indirekt von einem Trust gehalten werden, und 440.914 Aktien, die indirekt vom Ehepartner als Treuhänder gehalten werden; darüber hinaus werden weitereBestände von 9.624 und 2.798 Aktien ebenfalls in direkten oder indirekten Formen gemeldet. Der Bericht ist von einem Bevollmächtigten am 03.10.2025 unterzeichnet.

كارولن شواب-بومرانتز، مديرة SCHWAB CHARLES CORP (SCHW)، أبلغت عن مبيعات لأسهم الشركة العادية بموجب خطة تداول وفقاً للقاعدة 10b5-1. في 02/10/2025 تصرفت في 14,400 سهمًا بسعر متوسط وُزنّي قدره $92.5465 و9,600 سهمًا بسعر متوسط وُزنّي قدره $92.5545، وكل بيع تم عبر صفقات متعددة. تنص الإيداع أن الخطة 10b5-1 اعتمدت في 14 أغسطس 2024. عقب المعاملات المبلغ عنها، يدرج النموذج حيازات منبنية بمستفيدين متعددة، بما في ذلك 1,434,856.6599 سهمًا بشكل غير مباشر مملوكة بواسطة صندوق، و440,914 سهمًا بشكل غير مباشر مملوكة من قبل الزوج كوصي؛ كما أُبلغ عن ملكيات إضافية قدرها 9,624 و2,798 سهمًا بطرق مباشرة أو غير مباشرة. وقع التقرير من قبل وكيل عام في 03/10/2025.

Carolyn Schwab-Pomerantz,SCHWAB CHARLES CORP (SCHW)董事,在符合 10b5-1 规则的交易计划下,报告了公司普通股交易。于2025/10/02以加权平均价格 $92.5465卖出了 14,400股,另以加权平均价格 $92.5545卖出 9,600股,每笔交易均为多笔交易的组合。文件指出该 10b5-1 计划于 2024年8月14日被采用。在所报告的交易之后,表格列出各种受益持有,包括由信托间接持有的 1,434,856.6599 股以及由配偶作为受托人间接持有的 440,914 股;还报告了另外的 9,624 股和 2,798 股的直接或间接持有。该报告于 2025/10/03 由一位代理人签署。

Positive
  • Transactions were executed under a Rule 10b5-1 plan, indicating pre-specified trading intent
  • Significant indirect holdings remain (e.g., 1,434,856.6599 shares held by a trust)
Negative
  • None.

Insights

Insider sales executed under a pre-existing Rule 10b5-1 plan; holdings remain largely indirect.

The filing documents routine dispositions by director Carolyn Schwab-Pomerantz on 10/02/2025 under a Rule 10b5-1 plan adopted on August 14, 2024, which provides an affirmative defense to insider trading rules when conditions are met.

The reported weighted-average sale prices were approximately $92.55 across multiple trades, and the report shows substantial indirect holdings (e.g., 1,434,856.6599 shares held by a trust), indicating the sales did not extinguish significant ownership. This is a disclosure of insider liquidity activity rather than an operational development.

Carolyn Schwab-Pomerantz, una direttrice della SCHWAB CHARLES CORP (SCHW), ha riportato vendite di azioni comuni della società nell'ambito di un piano di negoziazione ai sensi della Regola 10b5-1. Il 02/10/2025 ha svalutato 14.400 azioni a un prezzo medio ponderato di $92,5465 e 9.600 azioni a un prezzo medio ponderato di $92,5545, ogni vendita effettuata in multiple transazioni. Il deposito riporta che il piano 10b5-1 è stato adottato l14 agosto 2024. A seguito delle transazioni riportate, il modulo elenca varie partecipazioni beneficiarie, tra cui 1.434.856,6599 azioni indirettamente detenute da un trust e 440.914 azioni indirettamente detenute dal coniuge in qualità di trustee; ulteriori partecipazioni di 9.624 e 2.798 azioni sono riportate anch'esse con forme dirette o indirette. Il rapporto è firmato da un procuratore-in-facto in data 03/10/2025.

Carolyn Schwab-Pomerantz, una directora de SCHWAB CHARLES CORP (SCHW), reportó ventas de acciones comunes de la empresa bajo un plan de negociación distinto conforme a la Regla 10b5-1. El 02/10/2025 liquidó 14,400 acciones a un precio medio ponderado de $92.5465 y 9,600 acciones a un precio medio ponderado de $92.5545, siendo cada venta realizada en múltiples operaciones. El registro indica que el plan 10b5-1 fue adoptado el 14 de agosto de 2024. Tras las transacciones reportadas, el formulario lista diversas participaciones beneficiosas, incluyendo 1,434,856.6599 acciones indirectamente en poder de un fideicomiso y 440,914 acciones indirectamente en poder del cónyuge como fiduciario; se reportan además participaciones de 9,624 y 2,798 acciones con formas directas o indirectas. El informe está firmado por un apoderado en 03/10/2025.

Carolyn Schwab-Pomerantz는 SCHWAB CHARLES CORP (SCHW)이사로서 회사 보통주를 매매한 것으로 Rule 10b5-1 거래 계획에 따라 매매를 보고했습니다. 2025/10/0214,400주를 가중 평균가 $92.5465로, 9,600주를 가중 평균가 $92.5545로 각 다수의 거래로 매도했습니다. 해당 제출 문서는 10b5-1 계획이 2024년 8월 14일에 채택되었다고 명시합니다. 보고된 거래에 따라 양식은 신탁이 간접적으로 보유한 1,434,856.6599주와 배우자가 신탁 수탁인으로 간접 보유한 440,914주를 포함한 여러 수혜 보유를 나열합니다; 또한 9,624주와 2,798주도 직접 또는 간접 형태로 보고됩니다. 보고서는 2025/10/03에 대리인에 의해 서명되었습니다.

Carolyn Schwab-Pomerantz, directrice de SCHWAB CHARLES CORP (SCHW), a déclaré des ventes d’actions ordinaires de la société dans le cadre d’un plan de négociation conforme à la règle 10b5-1. Le 02/10/2025, elle a cédé 14 400 actions à un prix moyen pondéré de $92,5465 et 9 600 actions à un prix moyen pondéré de $92,5545, chaque vente effectuée en plusieurs transactions. Le dépôt indique que le plan 10b5-1 a été adopté le 14 août 2024. Suite aux transactions signalées, le formulaire répertorie diverses participations bénéficiaires, notamment 1 434 856,6599 actions indirectement détenues par une fiducie et 440 914 actions indirectement détenues par le conjoint en tant que fiduciaire; d’autres participations de 9 624 et 2 798 actions sont également signalées sous des formes directes ou indirectes. Le rapport est signé par un mandataire en 03/10/2025.

Carolyn Schwab-Pomerantz, eine Direktorin der SCHWAB CHARLES CORP (SCHW), meldete Verkäufe von Stammaktien des Unternehmens im Rahmen eines Handelsplans gemäß der Regulierung 10b5-1. Am 02.10.2025 veräußerte sie 14.400 Aktien zu einem gewichteten Durchschnittspreis von $92,5465 und 9.600 Aktien zu einem gewichteten Durchschnittspreis von $92,5545, wobei jeder Verkauf in mehreren Transaktionen erfolgte. Die Einreichung besagt, dass der 10b5-1-Plan am 14. August 2024 angenommen wurde. Nach den gemeldeten Transaktionen listet das Formular verschiedene begünstigte Beteiligungen auf, darunter 1.434.856,6599 Aktien, die indirekt von einem Trust gehalten werden, und 440.914 Aktien, die indirekt vom Ehepartner als Treuhänder gehalten werden; darüber hinaus werden weitereBestände von 9.624 und 2.798 Aktien ebenfalls in direkten oder indirekten Formen gemeldet. Der Bericht ist von einem Bevollmächtigten am 03.10.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schwab-Pomerantz Carolyn

(Last) (First) (Middle)
3000 SCHWAB WAY

(Street)
WESTLAKE TX 76262

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SCHWAB CHARLES CORP [ SCHW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 S(1) 14,400 D $92.5465(2) 1,434,856.6599 I by Trust
Common Stock 10/02/2025 S(1) 9,600 D $92.5545(3) 440,914 I by Spouse as Trustee
Common Stock 9,624 D
Common Stock 2,798 I by LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.
2. This transaction was executed in multiple trades at prices ranging from $92.185 to $92.93. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. This transaction was executed in multiple trades at prices ranging from $92.185 to $92.94. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
/s/ P. Blake Allen, Attorney-in-fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SCHW director Carolyn Schwab-Pomerantz sell?

She sold 14,400 shares at a weighted-average price of $92.5465 and 9,600 shares at $92.5545 on 10/02/2025.

Were the sales part of a Rule 10b5-1 plan for SCHW?

Yes. The filing states the trades were effected pursuant to a Rule 10b5-1 plan adopted on August 14, 2024.

How many SCHW shares does the reporting person still beneficially own?

The form reports indirect holdings including 1,434,856.6599 shares by a trust and 440,914 shares by spouse as trustee, plus other reported amounts of 9,624 and 2,798 shares.

When was the Form 4 signed?

The filing is signed by an attorney-in-fact on 10/03/2025.

Were the sale prices single trades or multiple trades?

Each reported sale was executed in multiple trades; the filing reports weighted-average prices and provides price ranges for the individual trades.
Schwab (CHARLES) Corp. (The)

NYSE:SCHW

SCHW Rankings

SCHW Latest News

SCHW Latest SEC Filings

SCHW Stock Data

168.27B
1.70B
6.07%
84.67%
1.21%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
WESTLAKE